Literature DB >> 8340187

Widespread primary cutaneous infection with Mycobacterium fortuitum.

D A Rotman1, A Blauvelt, F A Kerdel.   

Abstract

BACKGROUND: Cutaneous infection with Mycobacterium fortuitum, a ubiquitous rapid growing atypical mycobacterium, most often occurs as a postsurgical wound complication or at the site of a penetrating injury to the skin. Rarely, disseminated infection with cutaneous involvement can occur in immunocompromised patients. CASE REPORT: A 47-year-old black woman presented with a 10-year history of numerous draining abscesses and tender nodules on the back and buttocks unresponsive to oral and intravenous antibiotics. Biopsy showed a granulomatous and suppurative dermatitis and panniculitis and special stains did not reveal organisms. M. fortuitum was cultured from involved skin on two separate occasions. The patient improved with a 2-week course of intravenous amikacin and cefoxitin combined with oral probenecid followed by a course of doxycycline and ciprofloxacin.
CONCLUSIONS: Widespread primary cutaneous infection with M. fortuitum may occur in an immunocompetent patient. Chronic draining skin abscesses unresponsive to routine antibiotics may represent infection with an atypical mycobacterium; tissue cultures of affected skin should be performed to rule out this possibility. Therapy should be directed by culture sensitivity results.

Entities:  

Mesh:

Year:  1993        PMID: 8340187     DOI: 10.1111/j.1365-4362.1993.tb02836.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

1.  Mycobacterium fortuitum Infections in Surgical Wounds.

Authors:  K K Lahiri; J Jena; K K Pannicker
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Mycobacterium ChelonaeDeveloping Multidrug Resistance.

Authors:  Vinod Kumar Mannelli; Manoj P Rai; Divyesh Reddy Nemakayala; Naga Preethi Kadiri
Journal:  BMJ Case Rep       Date:  2018-02-22

3.  Cutaneous Mycobacterium fortuitum Infection: Successfully Treated with Amikacin and Ofloxacin Combination.

Authors:  Sunil Sethi; Shilpa Arora; Vikas Gupta; Shiv Kumar
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.